CompletedNot applicableNCT02100397
Understanding Paratyphoid Infection
Studying Paratyphoid fever
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Oxford
- Principal Investigator
- Andrew Pollard, MBBSOxford Vaccine Group
- Intervention
- Salmonella enterica serovar Paratyphi A (strain NVGH308)(biological)
- Enrollment
- 80 enrolled
- Eligibility
- 18-60 years · All sexes
- Timeline
- 2014 – 2022
Study locations (1)
- Centre for Clinical Vaccinology and Tropical Medicine, Oxford, Oxfordshire, United Kingdom
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02100397 on ClinicalTrials.govOther trials for Paratyphoid fever
Additional recruiting or active studies for the same condition.